Related Experiment Video

Updated: May 26, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Targeting mitochondria in fighting cancer

Vladimir Gogvadze1

  • 1Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Vladimir.Gogvadze@ki.se

Current Pharmaceutical Design
|December 23, 2011
PubMed

Insights

Mitochondria play a key role in cancer and neurodegenerative diseases. Targeting mitochondrial functions offers a promising strategy for eliminating tumor cells and fighting cancer.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Mitochondria are increasingly recognized for their role in various diseases, including cancer and neurodegenerative disorders.
  • Dysfunctional mitochondria, affecting ATP production, calcium buffering, and reactive oxygen species generation, are implicated in disease pathogenesis.
  • Mitochondria are central to multiple cell death pathways, making them significant targets in cancer therapy.

Purpose of the Study:

  • To review the multifaceted role of mitochondria in the development and progression of cancer.
  • To explore the potential of targeting mitochondrial functions as a therapeutic strategy against cancer cells.

Main Methods:

  • Literature review of recent scientific reports and studies.
  • Analysis of the biochemical and cellular functions of mitochondria in the context of cancer.
  • Examination of therapeutic strategies targeting mitochondria.

Main Results:

  • Mitochondrial dysfunction is a significant factor in the pathogenesis of cancer and neurodegenerative diseases.
  • Altered mitochondrial functions, including energy production and oxidative stress, contribute to cancer development.
  • The involvement of mitochondria in cell death mechanisms presents opportunities for cancer treatment.

Conclusions:

  • Mitochondria are critical players in tumor cell biology and survival.
  • Targeting mitochondria represents a viable and promising approach for developing novel anti-cancer therapies.

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...